Newsroom | 11822 results

韩国安养--(BUSINESS WIRE)--(美国商业资讯)-- 韩国NEL动物医学基金会（理事长：Eom Tae-heum医生）宣布，于11月25日成功完成第100例犬类开胸手术，成为韩国首家达到该里程碑的兽医机构。这一成就距基金会2023年底成功完成首例二尖瓣修复手术仅两年，标志着高水平兽医胸外科手术进入了一个新时代。 过去，犬类心脏病被视为一种慢性疾病，只能通过药物治疗。然而，NEL动物医学基金会利用体外循环（CPB）技术，树立了外科治疗的新标杆。基金会展现出前所未有的增长势头，预计在2025年底将达到每周四台手术的峰值水平。 除手术量之外，NEL动物心脏团队也取得了卓越的临床疗效。2025年下半年，该团队的手术成功率超过97%，36只患病的动物中有35只成功出院。值得一提的是，所有动物均完全停止服用心脏药物，恢复了正常生活。 基金会还成功完成了一系列高难度病例，在全球范围内证明了其卓越的技术实力，其中包括： 为一只体重仅1.6公斤的超小型犬进行手术。 全球首例复杂室间隔缺损（VSD）手术矫正。 感染性心内膜炎（IE）的外科治疗。 这些成功源于基金会理事长Eom Tae-heu...

NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS) has received a $10 million gift from Lauren and Robert Steers to develop the HSS Digital Twin Platform, a groundbreaking technology designed to advance orthopedic surgical care across multiple joints and procedures. The revolutionary tool utilizes 3D imaging to create virtual replicas of a patient’s anatomy, enabling surgeons to run real-time, data-driven simulations for surgical planning, intraoperative decision-making and predictin...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the introduction of Genesis™ Radiology Workspace, a next-generation solution designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision. At the center of this innovation is Genesis™ View, 510(k) pending2, a powerful new viewer designed to be a fast diagnostic, zero-footprint viewer – streamlining radiology workflows with the intent to enhance patient care whil...

ANYANG, South Korea--(BUSINESS WIRE)--NEL Animal Medical Foundation has performed 100 canine open-heart surgeries, opening a new chapter in high-level veterinary thoracic surgery....

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leader in diagnostic and enterprise imaging solutions, will highlight its latest diagnostic imaging innovations in booth #3300 in South Hall at the Radiological Society of North America (RSNA) 2025 annual meeting, held November 30 to December 3 at McCormick Place in Chicago. These new imaging advances are built for today’s demanding clinical environments, delivering intelligent mobile bedside imaging, unique Deep Lea...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enable...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the publication of the third manuscript from Surveillance HeartCare Outcomes Registry (SHORE) in the Journal of Heart and Lung Transplantation (JHLT). The analysis, titled “Multimodal Molecular Testing Prov...

AIX-EN-PROVENCE, France & PARIS & STRASBOURG, France & TOURS, France--(BUSINESS WIRE)--Multidisciplinary group awarded in France 2030 Plan to develop next-generation software-based, smart, and frugal ultrasound imaging devices....

AIX-EN-PROVENCE, France & PARIS & STRASBOURG, France & TOURS, France--(BUSINESS WIRE)--Lauréat du plan France 2030, POCUSI incarne l’ambition française de souveraineté technologique en imagerie médicale. Composé de quatre partenaires nationaux, il vise à développer une nouvelle génération d’échographes logiciels, intelligents et frugaux, capables d’exploiter la puissance de calcul des ordinateurs ou des tablettes. Cette innovation doit répondre aux besoins croissants de dépistage, de surveillan...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) assigned VNS Therapy™, a LivaNova neuromodulation treatment for patients 4 years of age and older with Drug-Resistant Epilepsy (DRE) and focal seizures, to New Technology Ambulatory Payment Classification (APC) 1580 for new patient implants (NPIs) under the 2026 Medicare Hospital Outpatient Prospective Payment System....